OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer Immunotherapy via Targeting Cancer Stem Cells Using Vaccine Nanodiscs
Alireza Hassani Najafabadi, Jing Zhang, Marisa Aikins, et al.
Nano Letters (2020) Vol. 20, Iss. 10, pp. 7783-7792
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Engineered Nanoparticles for Cancer Vaccination and Immunotherapy
Marisa Aikins, Cheng Xu, James J. Moon
Accounts of Chemical Research (2020) Vol. 53, Iss. 10, pp. 2094-2105
Open Access | Times Cited: 181

Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Treatment
Shan Gao, Xiaoye Yang, Jiangkang Xu, et al.
ACS Nano (2021) Vol. 15, Iss. 8, pp. 12567-12603
Closed Access | Times Cited: 177

Bioinspired and Biomimetic Delivery Platforms for Cancer Vaccines
Jing Liu, Si Si Liew, Jun Wang, et al.
Advanced Materials (2021) Vol. 34, Iss. 1
Closed Access | Times Cited: 127

Nanodiscs: a versatile nanocarrier platform for cancer diagnosis and treatment
Jitender Bariwal, Hairong Ma, Guillermo A. Altenberg, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 5, pp. 1702-1728
Closed Access | Times Cited: 85

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies
Yan-Ruide Li, Ying Fang, Zibai Lyu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 68

Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
Heng Dong, Qiang Li, Yu Zhang, et al.
Advanced Science (2023) Vol. 10, Iss. 18
Open Access | Times Cited: 48

Non-spherical micro- and nanoparticles for drug delivery: Progress over 15 years
Neha Kapate, John R. Clegg, Samir Mitragotri
Advanced Drug Delivery Reviews (2021) Vol. 177, pp. 113807-113807
Open Access | Times Cited: 93

Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
Mahmoud S. Alghamri, Brandon L. McClellan, Carson S. Hartlage, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 60

Lymph node-targeting nanovaccines for cancer immunotherapy
Qiu Wang, Zhe Wang, Xinxin Sun, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 102-122
Closed Access | Times Cited: 46

Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy
Shaobo Ruan, Yuanyu Huang, Mei He, et al.
Advanced Science (2022) Vol. 9, Iss. 16
Open Access | Times Cited: 43

Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets
Jie Xia, Siqin Li, Suling Liu, et al.
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 42

Injectable hydrogels for personalized cancer immunotherapies
Neda Mohaghegh, Amir Ahari, Fatemeh Zehtabi, et al.
Acta Biomaterialia (2023) Vol. 172, pp. 67-91
Open Access | Times Cited: 31

Immunotargeting of Cancer Stem Cells
Ayşe Sedef Köseer, Simona Di Gaetano, Claudia Arndt, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1608-1608
Open Access | Times Cited: 30

Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells
Nimeet Desai, Uzma Hasan, K Jeyashree, et al.
Acta Biomaterialia (2023) Vol. 161, pp. 1-36
Open Access | Times Cited: 24

Endogenous/Exogenous Nanovaccines Synergistically Enhance Dendritic Cell‐Mediated Tumor Immunotherapy
Yu Zhang, Qiang Li, Meng Ding, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 17
Open Access | Times Cited: 23

Advancing nanotechnology for neoantigen-based cancer theranostics
Jianhua Zou, Yu Zhang, Yuanbo Pan, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 7, pp. 3224-3252
Open Access | Times Cited: 16

Engineering customized nanovaccines for enhanced cancer immunotherapy
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 14

Expanding the Role of Chiral Drugs and Chiral Nanomaterials as a Potential Therapeutic Tool
Sourabh Satapathy, Shivam Kumar, Balak Das Kurmi, et al.
Chirality (2024) Vol. 36, Iss. 7
Closed Access | Times Cited: 12

Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance
Zhijie Xu, Zhou Hai-yan, Tongfei Li, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101098-101098
Closed Access | Times Cited: 10

Two-dimensional nano-biomaterials in regulating the tumor microenvironment for immunotherapy
Guangyu Xu, Jie Li, Suming Zhang, et al.
Nano TransMed (2024) Vol. 3, pp. 100045-100045
Open Access | Times Cited: 9

LAG-3 and TIM-3 expression in melanoma and histopathological correlation: a single-center study
Mine İlayda Şengör Aygün, Özben Yalçın
Clinical & Translational Oncology (2025)
Closed Access | Times Cited: 1

Enhancing therapeutic performance of personalized cancer vaccine via delivery vectors
Tong Ye, Feng Li, Guanghui Ma, et al.
Advanced Drug Delivery Reviews (2021) Vol. 177, pp. 113927-113927
Closed Access | Times Cited: 50

A novel medically imageable intelligent cellulose nanofibril-based injectable hydrogel for the chemo-photothermal therapy of tumors
Zhiping Chen, Rimei Chen, Chao Zhao, et al.
Chemical Engineering Journal (2021) Vol. 431, pp. 133255-133255
Closed Access | Times Cited: 50

Biological applications of chiral inorganic nanomaterials
Yuan Fan, Shaobo Ou‐yang, Dong Zhou, et al.
Chirality (2022) Vol. 34, Iss. 5, pp. 760-781
Closed Access | Times Cited: 30

Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions
Yueyi Li, Li Shen, Zedong Jiang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18

Page 1 - Next Page

Scroll to top